The 20 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 56.80, with a high estimate of 65.34 and a low estimate of 36.60. The median estimate represents a +5.58% increase from the last price of 53.80.
The current consensus among 24 polled investment analysts is to Buy stock in AstraZeneca PLC. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.44
Reporting Date Jul 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.